Tops & Flops Stocks
| Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kineta Inc. | 6.970% | 4.878% | -14.851% | -84.307% | -86.478% | -99.505% | - |
| Athersys Inc. | 6.990% | - | - | - | - | - | - |
| Canopy Growth Corp | 7.100% | - | - | - | - | - | - |
| Grindeks AS | 7.330% | - | - | - | - | - | - |
| Infinity Pharmaceuticals Inc. | 7.360% | - | - | - | - | - | - |
| Sareum Holdings plc | 7.520% | 27.225% | 76.087% | -62.326% | -20.976% | -66.483% | - |
| Cellmid Ltd | 7.940% | - | - | - | - | - | - |
| Medivir AB | 8.040% | 11.521% | 5.677% | -58.462% | 10.603% | -70.050% | -85.979% |
| Emergent Biosolutions Inc. | 8.350% | 3.673% | 166.855% | -38.460% | 111.580% | -90.521% | -87.802% |
| Oncopeptides AB | 8.490% | 11.280% | -1.724% | -63.104% | -63.115% | -97.349% | - |
| Akebia Therapeutics Inc. | 8.640% | -1.974% | -15.561% | 12.077% | -15.273% | -65.521% | - |
| Seres Therapeutics Inc | 8.750% | 1.585% | -7.415% | -80.388% | -34.427% | -95.371% | - |
| Osmotica Pharmaceuticals PLC | 8.780% | - | - | - | - | - | - |
| Mediwound Ltd. | 8.780% | 0.625% | -9.040% | 84.000% | 78.889% | 479.137% | 359.344% |
| PharmAust Ltd. | 8.780% | -21.845% | -22.596% | 106.410% | 30.894% | 54.808% | 373.529% |
| NanoViricides Inc. | 9.090% | 9.091% | 94.595% | 116.000% | 128.571% | -27.076% | -49.367% |
| Alimera Sciences | 9.190% | - | - | - | - | - | - |
| Genetic Technologies Ltd. | 10.430% | 0.000% | 11.404% | 12600.000% | -13.605% | 1487.500% | 3075.000% |
| Ziopharm Oncology | 11.930% | - | - | - | - | - | - |
| Bionomics Ltd. | 12.120% | - | - | - | - | - | - |
| Promis Neurosciences Inc. | 12.240% | 10.738% | -5.172% | -65.336% | 65.829% | -79.853% | -84.463% |
| Hansa Medical AB | 12.700% | 7.167% | 58.250% | -8.128% | 54.894% | -71.991% | - |
| Genfit S.A. | 13.030% | 31.470% | 69.859% | 38.896% | 50.069% | 63.741% | -74.954% |
| India Globalization Capital | 13.860% | -0.862% | 24.324% | 88.525% | 75.573% | -58.521% | -53.347% |
| Cytocom Inc. | 13.970% | - | - | - | - | - | - |